SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense investor frustration as the stock continues a sharp, multi-week decline that has decoupled from broader market gains. The community is actively debating whether this represents an oversold buying opportunity, a structural shift due to mounting AI infrastructure costs and integration concerns, or deliberate algorithmic manipulation.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention as retail investors rotate into the stock to gain exposure to high-profile private companies like SpaceX and Anthropic ahead of potential IPOs. Community sentiment is driven by a mix of speculative trading momentum, discussions around the fund's portfolio concentration compared to peers, and anticipation that share scarcity could spark a rapid move toward historical highs.

The Shrimp Army

SHRIMPS is gaining traction as part of a broader trend of aquatic-themed memecoins, with investors debating the potential for rapid gains versus the volatility typical of highly speculative pump-and-dump cycles. The community remains focused on momentum-driven price action and the ability to maintain current levels while comparing the token to other recent market participants in the sector.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently the center of intense debate as traders react to a significant business model shift involving the launch of an in-house AGI CPU, with the community split between bullish sentiment over long-term AI-driven revenue growth and skepticism regarding the stock's valuation. Investors are actively discussing the potential for market share gains in the data center space, while some bears caution against chasing the stock due to lofty expectations and broader semiconductor sector volatility.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is facing intense volatility following a highly critical report from Culper Research that alleges the company is engaging in channel stuffing and misleading financial reporting. While the stock has seen a sharp sell-off, the community is deeply divided, with many long-term shareholders dismissing the report as a tactical short-seller attack and urging management to provide a more aggressive, detailed rebuttal to restore market confidence.

PRIME is the native token of the Echelon Prime Foundation, a Web3 ecosystem advancing the next generation of gaming. Echelon creates and distributes tools to encourage innovation in, and promote the growth of, novel gaming models and economies. The first game to adopt and utilize PRIME is Parallel, a sci-fi trading card game.

Echelon Prime

Echelon Prime is trending as community members highlight its role as the backbone of on-chain gaming economies, driving speculation about a potential rally fueled by the broader recovery in altcoins. Investors are actively debating accumulation strategies and technical breakouts while looking for signs that the token is poised for a significant move amid the expanding Web3 gaming sector.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently the focal point of intense market debate as investors grapple with its aggressive capital-raising strategy and heavy reliance on Bitcoin accumulation. The community is sharply divided, with bulls pointing to the company's long-term Bitcoin treasury strategy as a high-conviction play, while skeptical traders and bears emphasize the risks of ongoing share dilution and the stock's high volatility relative to broader market movements.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors react to extreme price volatility and speculative momentum, fueled by the fund's heavy exposure to private AI and space exploration leaders like OpenAI, Anthropic, and SpaceX. The community is intensely debating whether the current premium to net asset value represents a historic opportunity or a classic bubble, with many actively rotating capital into similar vehicles like DXYZ and ORBS to gain comparable exposure at more favorable valuations.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron shares are under intense pressure as algorithmic traders react to a Google research announcement regarding an AI memory compression algorithm, while investors continue to weigh the impact of the company's large-scale debt repurchase plan. The community is deeply divided between those viewing the pullback as a buying opportunity given the firm's strong fundamentals and those fearing that recent headline-driven volatility signals a potential cyclical peak.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently experiencing extreme volatility following a disappointing earnings report and significant insider share sales by CEO Lourenco Goncalves, which has fueled widespread anxiety regarding debt levels and the viability of the long-anticipated POSCO partnership. While bears warn of structural weakness and potential bankruptcy risks, a vocal segment of the retail community is aggressively buying the dip, labeling the sell-off as a manipulative shakeout and pointing to the company's domestic steel moat and HRC pricing as reasons for an inevitable rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Promis Neurosciences (NASDAQ:PMN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the four brokerages that are covering the stock, MarketBeat.com reports. One...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 1,000 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 1,000 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was bought at an average cost...

Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams bought 1,000 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was purchased at an average...

Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 2,000 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were...

Promis Neurosciences (NASDAQ:PMN) Insider Buys $25,005.15 in Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) insider Johanne Kaplan bought 1,629 shares of Promis Neurosciences stock in a transaction on Thursday, February 19th. The shares were purchased at...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Major Shareholder Acquires 700,741 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) major shareholder Abg Management Ltd. bought 700,741 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The...

ProMIS Neurosciences Secures $175 Mln In Private Financing

(RTTNews) - ProMIS Neurosciences Inc. (PMN), a clinical-stage biotechnology company, has announced on Friday a private investment in public equity financing of up to approximately $175 million...

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.06	--	--	N/A
Q4 '25	-$4.66	-$4.11	11.80%	BEAT
Q3 '25	-$0.29	-$6.00	-1968.97%	MISSED
Q2 '25	-$0.17	-$0.29	-66.76%	MISSED
Q1 '25	-$0.12	-$0.21	-75.00%	MISSED

PMN
ProMIS Neurosciences

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest PMN News

PMNProMIS Neurosciences